Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell symbols : Mor save search
Incyte and MorphoSys Announce the European Commission Approval of Minjuvi® (tafasitamab) in Combination With Lenalidomide for the Treatment of Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-08-26 (Crawled : 21:00) - biospace.com/
XNCR | $18.95 -0.63% -0.47% 470K
|
Health Technology
|
| O: 0.28%
H: 0.89%
C: -2.02%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: -0.49%
H: 1.34%
C: -0.42%
INCY | $52.82 0.19% 0.19% 1.5M
|
Health Technology
|
| O: 0.25%
H: 0.33%
C: -1.05%
treatment europe approval t-cell
Incyte Announces Health Canada Approval of Minjuvi (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-08-24 (Crawled : 13:00) - biospace.com/
XNCR | $18.95 -0.63% -0.47% 470K
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: -2.7%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: 4.43%
H: 0.21%
C: -0.55%
INCY | $52.82 0.19% 0.19% 1.5M
|
Health Technology
|
| O: 0.3%
H: 0.03%
C: -0.29%
canada approval treatment approval t-cell
MorphoSys and Incyte Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 13:00) - biospace.com/
XNCR | $18.95 -0.63% -0.47% 470K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $52.82 0.19% 0.19% 1.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 12:15) - biospace.com/
XNCR | $18.95 -0.63% -0.47% 470K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | $18.05 0.06% -0.11% 590K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $52.82 0.19% 0.19% 1.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.